Needle assembly for forming hole through biological wall

Abstract

To provide a needle assembly that can prevent the removal of a free-floating tissue core from a biological wall.SOLUTION: A needle assembly 102 is configured to be movable into a cavity 900 of a patient 902 having a biological wall 904. A distal tip section 104 extends from the needle assembly. The distal tip section 104 is configured to form a through hole 905 extending through the biological wall 904 of the patient 902 (when or while the needle assembly 102 is urged to move toward the biological wall 904). The distal tip section 104 is also configured to prevent (at least in part) the removal of a free-floating tissue core from the biological wall 904 when the through hole 905 is formed by the distal tip section 104.SELECTED DRAWING: Figure 3

Description

[Technical field]

[0001] This document relates to (and is not limited to) the technical field of needle assemblies configured to be movable into a patient having a biological wall, and to needle assemblies (and methods therefor) configured to form a through hole extending through the biological wall of the patient. [Background technology]

[0002] A medical needle assembly is a medical tool configured to penetrate a biological wall of a patient and may or may not include a passageway extending along the length of the medical needle assembly. Summary of the Invention

[0003] It will be appreciated that a need exists to alleviate (at least in part) at least one problem associated with existing needle assemblies (also referred to as existing technology). After much research and experimentation with existing needle assemblies, an understanding (at least in part) of the problem and a solution thereto has been identified (at least in part) and articulated (at least in part) as follows:

[0004] Radiofrequency needles are commonly used to puncture the atrial septum in transseptal catheterization of the heart. They work by vaporizing target tissue when radiofrequency energy is delivered through an active electrode at the distal tip. This is in opposition to mechanical needles, which puncture the atrial septum using mechanical force delivered by the user. Radiofrequency needles require less input force to puncture, have improved precision to puncture location, reduce the risk of inadvertent mechanical puncture (due to their blunt tip compared to mechanical needles), and may eliminate (or reduce) some user functions.

[0005] Mechanical needles used to puncture the atrial septum are typically characterized as having a hollow or open lumen. This open lumen allows for contrast delivery directly to the targeted site of the puncture and provides visual confirmation under fluoroscopic imaging for the user. Additionally, the open lumen allows pressure measurements to be made and allows the user to confirm the region of the heart in which they are located. Finally, the open lumen facilitates fixation of a guidewire that is placed through the needle to fixate (anchor) the puncture location extending from the right atrium to the left atrium of the patient's heart.

[0006] Radiofrequency needles with open lumens deliver the above features to users accustomed to mechanical needles while still retaining the benefits of radiofrequency-based puncture of the atrial septum. However, one problem is the suspected of "coring" tissue upon puncture. An electrically active open lumen is characterized by a closed path of conductive material that vaporizes the tissue it encounters. However, the surrounding interior formed by the closed conductive path does not vaporize, but instead, all the surrounding tissue vaporizes, thus separating it from the larger wall of tissue it was a part of. This action is similar to how a hole punch creates (forms) another disk of paper from a larger piece of paper. Having a free-floating core of tissue in the bloodstream is highly undesirable due to the risk of causing a stroke or pulmonary embolism in the patient. Therefore, any open lumen radiofrequency needle would require a method to prevent this from occurring.

[0007] Known radiofrequency transseptal needles are commonly used because they are mechanical transseptal needles. When viewed from the lens of the puncture modality, there are clear advantages and disadvantages to both open and closed lumens. Ideally, a product that provides the benefits of an open lumen with a radiofrequency puncture modality would combine the advantages currently offered by both mechanical and radiofrequency transseptal needles. Open lumen RF delivery devices for puncturing the fossa ovalis in the heart are well known to those skilled in the art.

[0008] FIG. 1 illustrates a cross-sectional view of one embodiment of a known needle assembly having a known distal tip section.

[0009] With reference to the embodiment shown in FIG. 1, the known needle assembly defines a known lumen extending the length of the known needle assembly. The known needle assembly is configured to be movable into a cavity of a patient having a biological wall (internal biological wall). A known distal tip section extends (distally) from the known needle assembly. The known distal tip section is configured to form a through hole extending through the biological wall of the patient when (during) the known needle assembly is biased to move toward the biological wall. The known distal tip section is configured to form a free-floating tissue core (shown in the known embodiment of FIG. 1) from the biological wall when (or during) a through hole is formed by the distal tip section in response to moving the known needle assembly toward the biological wall. The known distal tip section is configured to form a free-floating tissue core from the biological wall, which may be provided by assistance from or the presence of an entrance of the known lumen. As the known distal tip section penetrates the biological wall, the entrance of the known lumen cuts and forms the free-floating tissue core.

[0010] The formation of a free-floating tissue core within a patient can be disadvantageous (or dangerous) For example, a free-floating tissue core can form in the patient's heart and then freely travel through the circulatory system to the brain, potentially causing a stroke or the like.

[0011] It may therefore be advantageous to provide a needle assembly having a distal tip section configured to prevent removal of the free-floating tissue core from the biological wall when (or during) the through hole is formed by the distal tip section.

[0012] To at least partially alleviate at least one problem associated with existing technology, an apparatus is provided (according to a main aspect). The apparatus includes, but is not limited to, a needle assembly configured to be movable into a cavity of a patient having a biological wall. A distal tip section extends (distally) from the needle assembly. The distal tip section is configured to form a through hole extending through the patient's biological wall when (during) the needle assembly is biased to move toward the biological wall. The distal tip section is also configured to prevent removal of a free-floating tissue core (shown in the embodiment of FIG. 1) from the biological wall when (or during) the through hole is formed by the distal tip section.

[0013] To at least partially alleviate at least one problem associated with the existing technology, an apparatus is provided (according to a main aspect). The apparatus includes, but is not limited to, a needle assembly configured to be movable into a cavity of a patient having a biological wall. A distal tip section extends (distally) from the needle assembly. The distal tip section surrounds a luminal entrance that leads to a lumen extending inwardly along the length of the needle assembly. The distal tip section is configured to form a through hole extending through the biological wall of the patient when (during) the needle assembly is biased to move toward the biological wall. The distal tip section is also configured to (at least partially) prevent removal of a free-floating tissue core (shown in the embodiment of FIG. 1), which may result from assistance from or the presence of a luminal entrance from the biological wall when (or during) the through hole is formed by the distal tip section.

[0014] To at least partially alleviate at least one problem associated with existing technology, a method is provided (according to a principal aspect). The method is for forming a through hole through a biological wall of a patient having a cavity. The method includes, but is not limited to, moving a needle assembly into a cavity of a patient having a biological wall, the needle assembly including a distal tip section extending (distally) from the needle assembly. The method also includes using the distal tip section to form a through hole through the biological wall of the patient when (while) the needle assembly is biased to move toward the biological wall. The method includes using the distal tip section to prevent removal of a free-floating tissue core (shown in the embodiment of FIG. 1 ) from the biological wall when (or while) the through hole is formed by the distal tip section.

[0015] To at least partially alleviate at least one problem associated with existing technology, a method is provided (according to a principal aspect). The method is for forming a through hole through a biological wall of a patient having a cavity. The method includes, but is not limited to, moving a needle assembly into a cavity of a patient having a biological wall, the needle assembly including a distal tip section extending (distally) from the needle assembly, the distal tip section surrounding a luminal entrance leading to a lumen extending therein along a length of the needle assembly. The method also includes using the distal tip section to form a through hole through the biological wall of the patient when the needle assembly is biased to move toward the biological wall. The method also includes using the distal tip section to prevent removal of a free-floating tissue core (as shown in the embodiment of FIG. 1 ) from the biological wall when the through hole is formed by the distal tip section (which may result from assistance from or the presence of the luminal entrance).

[0016] Other aspects are identified in the claims. Other aspects and features of the non-limiting embodiments may now become apparent to those skilled in the art upon review of the following detailed description of the non-limiting embodiments with the accompanying drawings. This summary is provided to introduce concepts in a simplified form that are further described below in the detailed description. This summary is not intended to identify potentially significant features or possible essential features of the disclosed subject matter, nor is it intended to describe each disclosed embodiment or every implementation of the disclosed subject matter. Many other novel advantages, features, and relationships will become apparent as this description proceeds. The figures and the following description more particularly exemplify exemplary embodiments. [Brief description of the drawings]

[0017] Non-limiting embodiments may be more fully understood by reference to the following detailed description of non-limiting embodiments when taken in conjunction with the accompanying drawings. [Figure 1] 1 shows a cross-sectional view of an embodiment of a known needle assembly having a known distal tip section. [Diagram 2] FIG. 1 illustrates a side view of an embodiment of a needle assembly having a distal tip section. [Diagram 3] FIG. 1 illustrates a side view of an embodiment of a needle assembly having a distal tip section. [Figure 4] FIG. 1 illustrates a side view of an embodiment of a needle assembly having a distal tip section. [Diagram 5] FIG. 3 shows a perspective view of the embodiment of the needle assembly of FIG. 2. [Figure 6] 3 illustrates an end view of the needle assembly embodiment of FIG. 2. [Figure 7] 3 shows a cross-sectional view of the embodiment of the needle assembly of FIG. 2. [Figure 8] FIG. 3 shows a side view of the embodiment of the needle assembly of FIG. 2. [Figure 9] FIG. 3 shows a side view of the embodiment of the needle assembly of FIG. 2. [Figure 10] FIG. 3 shows a side view of the embodiment of the needle assembly of FIG. 2. [Figure 11] FIG. 3 shows a perspective view of the embodiment of the needle assembly of FIG. 2. [Figure 12] FIG. 3 shows a perspective view of the embodiment of the needle assembly of FIG. 2. [Figure 13] FIG. 3 illustrates a perspective view of an embodiment of the needle assembly of FIG. 2.

[0018] The drawings are not necessarily to scale and may be shown in phantom lines, schematic diagrams, and partial views. In certain instances, details unnecessary for understanding the embodiments (and / or details that make other details difficult to perceive) may be omitted. Corresponding reference characters indicate corresponding components throughout the several views of the drawings. Elements in the various figures are shown for simplicity and clarity and are not drawn to scale. Dimensions of some of the elements in the figures may be exaggerated relative to other elements to facilitate understanding of the various embodiments disclosed. Additionally, common and well-understood elements useful in commercially viable embodiments are often not shown to provide an unobstructed view of the embodiments of the present disclosure.

[0019] [Table 1] DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0020] The following detailed description is merely exemplary and is not intended to limit the described embodiments or the application and uses of the described embodiments. As used, the word "exemplary" or "exemplary" means "serving as an example, instance, or illustration." Any implementation described as "exemplary" or "exemplary" should not necessarily be construed as preferred or advantageous over other implementations. All of the implementations described below are example implementations provided to enable one of ordinary skill in the art to make or use embodiments of the disclosure and are not intended to limit the scope of the disclosure. The scope of the disclosure is defined by the claims. For purposes of description, the terms "upper," "lower," "left," "rear," "right," "front," "vertical," "horizontal," and derivatives thereof, shall refer to the examples oriented in the drawings. No binding is intended by any expressed or implied theory in the preceding technical field, background, abstract, or the following detailed description. It should also be understood that the devices and processes illustrated in the accompanying drawings and described in the following specification are example embodiments, aspects, and / or concepts defined in the appended claims. Therefore, dimensions and other physical characteristics related to the disclosed embodiments should not be considered limiting unless the claims expressly state otherwise. The phrase "at least one" is understood to be equivalent to "one (a)". Aspects (examples, modifications, variations, alternatives, variations, embodiments, and any equivalents thereof) are described with respect to the drawings. It is understood that the disclosure is limited to the subject matter provided by the claims, and that the disclosure is not limited to the specific aspects shown and described. It is understood that the scope of the meaning of a device configured to be coupled to an article (i.e., connected to an article, interacting with an article, etc.) is to be interpreted as the device being configured to be coupled to an article either directly or indirectly. Thus, "configured to" may include the meaning of "either directly or indirectly" unless otherwise specified.

[0021] 2, 3 and 4 show side views of an embodiment of a needle assembly 102 having a distal tip section 104.

[0022] Referring to the embodiment shown in FIG. 2, the needle assembly 102 may be configured to be inserted into a confined space defined by the patient 902. The needle assembly 102 may be configured to guide the insertion of a medical instrument (known, not shown, such as a catheter, and any equivalents thereof) into the confined space defined by the patient 902. The needle assembly 102 includes, but is not limited to, an elongated flexible tube (made from a medical grade material) configured to be inserted into the patient 902. The needle assembly 102 is (preferably) impermeable by the bodily fluids of the patient 902. The needle assembly 102 includes (according to an alternative option) superelastic nitinol. Nitinol alloys exhibit two closely related unique properties: shape memory effect (SME) and superelasticity (SE; also called pseudoelasticity or PE). Shape memory is the ability of Nitinol to deform at a temperature and then recover its original undeformed shape upon heating above its transformation temperature. Superelasticity occurs in a narrow temperature range just above its transformation temperature, where no heating is required to recover the undeformed shape and the material exhibits extremely high elasticity, approximately 10-30 times that of ordinary metals. The needle assembly 102 may include a shape memory material configured to return to the original shape to which the material was set after manipulation and / or deformation. Shape memory materials (SMMs) are configured to recover to their original shape from an apparently large plastically deformed state in response to a particular stimulus applied to the material. This may be known as the shape memory effect (SME). Superelasticity (in alloys) may be observed when a shape memory material deforms upon application of a stimulus. The needle assembly 102 may comprise any biocompatible material having suitable properties with sufficient performance characteristics (dielectric strength, thermal performance, insulation and corrosion, water and heat resistance) for safe performance in compliance with industrial and regulatory safety standards (or suitable for medical use).For considerations in the selection of suitable materials, reference is made to the following publication: Plastics in Medical Devices: Properties, Requirements, and Applications, 2nd Edition, Author: Vinny R. Sastri, Hardcover ISBN: 9781455732012, Published: November 21, 2013, Publisher: Amsterdam [Pays-Bas]: Elsevier / William Andrew, [Published 2014].

[0023] With reference to the embodiment as shown in Figures 2, 3, and 4, the main aspects of the device are shown. The device includes, but is not limited to, a needle assembly 102. The needle assembly 102 is configured to be movable into a cavity 900 of a patient 902 having a biological wall 904 (an internal biological wall). A distal tip section 104 extends (distally) from the needle assembly 102. The distal tip section 104 surrounds (at least partially) a luminal entrance 106. The luminal entrance 106 leads to a lumen 108. The lumen 108 extends (at least partially) internally along the length of the needle assembly 102. The distal tip section 104 is configured to form a through hole 905 (which, when formed, extends through the biological wall 904 of the patient 902) when the needle assembly 102 is biased to move towards the biological wall 904. The distal tip section 104 is also configured to (at least partially) prevent removal of the free-floating tissue core 906 (as shown in the embodiment of FIG. 1), which may be provided by assistance from or the presence of a luminal entrance 106 from the biological wall 904 (when or during the through hole 905 is formed by the distal tip section 104).

[0024] With reference to the embodiment shown in Figures 2, 3, and 4, the distal tip section 104 is also configured to form a tissue flap 908 that remains attached to the biological wall 904 and extends therefrom (preferably, the tissue flap 908 (as shown in Figure 4) is positioned proximate to the through hole 905 when or during the time the through hole 905 is formed by the distal tip section 104).

[0025] With reference to the embodiment as shown in Figures 2, 3, and 4, the main aspects of a method are illustrated. The method is for forming a through hole 905 through a biological wall 904 of a patient 902 having a cavity 900. The method includes, but is not limited to, including a first operation including moving a needle assembly 102 into the cavity 900 of the patient 902. The needle assembly 102 includes a distal tip section 104 extending (distally) from the needle assembly 102. The distal tip section 104 surrounds a luminal entrance 106 that leads to a lumen 108 extending inwardly along the length of the needle assembly 102. The method also includes, but is not limited to, including a second operation including using the distal tip section 104 to form a through hole 905 through the biological wall 904 of the patient 902 as the needle assembly 102 is urged to move toward the biological wall 904. The method also includes, and is not limited to, a third action including using the distal tip section 104 to prevent removal of a free-floating tissue core 906 (shown in the embodiment of FIG. 1 ) from the biological wall 904 (which may provide assistance from, or the presence of, the lumen entrance 106 (when or during the through hole 905 is formed by the distal tip section 104).

[0026] With reference to the embodiment shown in Figures 2, 3, and 4, the needle assembly 102 may, for example, enable a user (surgeon) to perform a transseptal puncture across the fossa ovalis of the heart of a patient 902.

[0027] With reference to the embodiment shown in Figures 2, 3, and 4, the needle assembly 102 comprises (preferably) SAE (Society of Automotive Engineers) number 304 stainless steel containing chromium (about 15% to about 20%) and nickel (about 2% to about 10.5%). The needle assembly 102 is (preferably) made of an electrically conductive material and provides a rigid profile suitable for surgical procedures. It will be understood that any electrically conductive material may be used for the needle assembly 102.

[0028] 2, 3 and 4, a molded plastic handle (known and not shown) may be positioned at the proximal end of the needle assembly 102. The molded plastic handle may allow for manipulation of the needle assembly 102 at its proximal end. It will be appreciated that the handle provides added convenience for the user.

[0029] 2, 3, and 4, a connection facilitating cable (known and not shown) is configured to electrically connect the distal tip section 104 (via the needle assembly 102) to a radio frequency energy generator (known and not shown). The cable is configured to facilitate electrical connection to the needle assembly 102 for delivery of radio frequency energy (from the radio frequency energy generator) to the needle assembly 102 at the distal tip section 104 to the biological wall 904 (target tissue).

[0030] 2, 3, and 4, the overall length of the needle assembly 102 may be compatible with conventional transseptal sheaths and dilators (known and not shown). This facilitates improved usability of the needle assembly 102 across a variety of accessory devices at the user's disposal. For example, the overall length of the needle assembly 102 may be about 71 centimeters (cm), about 89 cm, or about 98 cm, etc.

[0031] 2, 3, and 4, the needle assembly 102 (preferably) has a distal section diameter that is compatible with conventional transseptal attachment devices (known and not shown). The distal section of the needle assembly 102 (preferably) does not exceed about 0.032 inches in diameter. Alternatively, the distal section of the needle assembly 102 does not exceed about 0.035 inches in diameter.

[0032] 2, 3, and 4, the needle assembly 102 can have an overall length that is compatible with conventional transseptal attachment devices. The overall length of the needle assembly 102 can be any length. The needle assembly 102 can be a length that allows the needle assembly 102 to reach the fossa ovalis of the interatrial septum of the patient's 902 heart (from where the user percutaneously accessed the vasculature).

[0033] With reference to the embodiment shown in Figures 2, 3, and 4, the needle assembly 102 may have a distal section diameter that may be of any suitable size and / or may not exceed a diameter that unduly impedes blood flow within the vasculature through which the needle assembly 102 passes.

[0034] With reference to the embodiment shown in Figures 2, 3 and 4, a circular profile of the needle assembly 102 and / or distal tip section 104 may provide maximum compatibility with existing attachment devices, although the needle assembly 102 may have any suitable shape.

[0035] With reference to the embodiment shown in Figures 2, 3, and 4, alternative options may include the following: Instead of the needle assembly 102 being made of a conductive material with a dielectric surface 112 (dielectric coating) covering at least one or more sections of the distal tip section 104, the materials may be reversed. The needle assembly 102 may be constructed where the needle assembly 102 is composed of an electrically insulating material and a portion of the distal tip section 104 is made of a conductive material. The distal tip section 104 having a conductive material may be connected to a known device configured to generate radio frequency energy via a conduit (wire) of conductive material that is internal (or external or both) to the needle assembly 102.

[0036] 2, 3 and 4, the needle assembly 102 may include a radio frequency needle constructed with a flap on the distal end made of a non-conductive material that closes the open lumen when radio frequency energy is applied thereto. This configuration may prevent tissue coring (as shown in FIG. 1) because there is no vaporization of the tissue along a closed circumferential path that may cause the tissue to split into multiple segments. Following application of radio frequency energy, the flap may be moved to a position where it no longer occludes the lumen 108 of the needle assembly 102.

[0037] With reference to the embodiment shown in Figures 2, 3, and 4, the needle assembly 102 may include a radio frequency needle constructed with a closed distal end that is used to apply radio frequency energy to a target tissue. A lumen is exposed on the side of the needle assembly 102 near the distal tip section 104. The lumen 108 may facilitate functions such as fluid delivery and aspiration, wire fixation, and pressure measurement. Tissue coring (as shown in Figure 1) may be avoided because the distal tip section 104 (when activated when radio frequency energy is applied) is not a circumferential profile that may cause tissue disruption into multiple segments.

[0038] With reference to the embodiment shown in Figures 2, 3 and 4, a radio frequency needle is (preferably) constructed in which the open lumen at the distal tip is made of a discontinuous conductive material. It is discontinuous in that it does not create a completely enclosed perimeter of conductive material at the distal end. Such a construction would require a mechanism to ensure that as the needle penetrates tissue beyond the discontinuous distal end, the needle is no longer electrically active and therefore cannot core tissue.

[0039] With reference to the embodiment shown in FIG. 4, rather than a needle assembly 102 (also referred to as a puncture device) having a lumen entrance 106 leading to a lumen 108, an open lumen cannula system may be provided with an attached radiofrequency guidewire (known and not shown). The open lumen cannula system may provide a conduit to a desired puncture location (such as through hole 905) in the fossa ovalis of the atrial septum of the heart of a patient 902. Through the conduit, a guidewire (known and not shown) may be advanced to the desired puncture location. The guidewire may have a core of conductive material surrounded by electrical insulation except at the distal tip and proximal end to facilitate connection to a device (known and not shown) that generates radiofrequency energy. Through the guidewire, radiofrequency energy may be applied to the through hole 905 to vaporize tissue without tissue coring (as shown in FIG. 1).

[0040] 5 and 6 show a perspective view (FIG. 5) and an end view (FIG. 6) of an embodiment of the needle assembly 102 of FIG.

[0041] With reference to the embodiment depicted in FIG. 5 (perspective view), the needle assembly 102 defines a lumen 108 (extending along the elongated length of the needle assembly 102). The needle assembly 102 preferably includes (is made of) an electrically conductive material. The needle assembly 102 preferably includes an electrically conductive surface 110. The needle assembly 102 also preferably includes a dielectric surface 112 (also referred to as a dielectric coating) that covers a portion or portions of the distal tip section 104 (such as a portion of the circumference of the distal tip section 104). The dielectric surface 112 provides electrical insulation to at least one or more selected regions of the distal tip section 104 (such that tissue in contact with the dielectric surface 112 is not vaporized). Thus, tissue contacted by the dielectric surface 112 is not completely separated during a puncture procedure associated with utilization of the needle assembly 102. By using the known needle assembly 802 (as shown in FIG. 1), rather than forming a free-floating tissue core 906 (as shown in the embodiment of FIG. 1), the dielectric surface 112 can completely avoid the formation of the free-floating tissue core 906. For example, the dielectric surface 112 may assist in the formation of a tissue flap 908 (as shown in FIG. 4) as an option or alternative to the embodiment shown in FIG. 1, but a through hole 905 is formed by the movement of the distal tip section 104 through the biological wall 904 (to allow a portion of the needle assembly 102 to penetrate the biological wall 904). The embodiment of FIG. 5 avoids the formation of a free-floating tissue core 906 (i.e., no tissue coring occurs), as shown in FIG. 1.

[0042] 4 and 5, a safety cover 114 is (preferably) applied to cover the exterior surface of the needle assembly 102 (as shown in FIG. 4). The safety cover 114 comprises an electrically insulating material. The safety cover 114 covers the remainder of the needle assembly 102, except for the distal tip section 104. The safety cover 114 may comprise a heat shrink material or the like. The safety cover 114 comprises a heat shrink having (preferably) polytetrafluoroethylene (PTFE), which may provide relatively greater lubricity compared to parylene, which may facilitate delivery to and removal from ancillary devices (not known and not shown) and / or the vasculature of a patient (the vasculature of a body part and its location). Only a relatively small section of the distal tip section 104 is coated with the dielectric surface 112 (as shown in FIG. 5), while the remainder of the needle assembly 102 is preferably covered with the safety cover 114 (heat shrink). It will be appreciated that the safety cover 114 may include any electrically insulating material and / or may include a dielectric coating as described herein.

[0043] 4 and 5, the dielectric surface 112 (dielectric coating) partially covers the circumference of the distal tip section 104 and / or the circumferential peripheral leading edge 105 of the distal tip section 104. The uncoated portion of the distal tip section 104 (the electroactive portion or conductive surface 110) is used to vaporize tissue (as shown in FIG. 4) in a desired portion of the biological wall 904 (such as the fossa ovalis of the heart) when the conductive surface 110 is activated or energized (e.g., when radio frequency energy is transmitted to a portion of the biological wall 904 via the conductive surface 110). Tissue coring (as shown in FIG. 1) is mitigated by the dielectric surface 112 (dielectric coating) preventing vaporization of tissue (the portion of the biological wall 904 as shown in FIG. 4). Preventing cutting (e.g., vaporization), tissue separation (i.e., tissue coring as shown in FIG. 1 ) by at least one section (or several sections) of the distal tip section 104 (or of the circumference of the distal tip section 104) can be at least partially avoided or prevented (e.g., when the conductive surface 110 is activated, such as when high frequency energy is applied to the conductive surface 110).

[0044] 5, the distal tip section 104 (preferably) includes a radio frequency tip assembly (known by those skilled in the art and not shown). One embodiment of the radio frequency may include the NRG™ RF Transseptal Needle manufactured by Baylis Medical (headquartered in Canada) and is configured to assist the physician in accessing the left atrium by using radio frequency (RF) energy in a controlled manner as opposed to mechanical force.

[0045] With reference to the embodiment shown in FIG. 5, the needle assembly 102 is made of an electrically conductive material. A dielectric coating covers a portion of the electrically conductive material. The distal tip section 104 is (preferably) configured to pierce a biological wall 904 (also referred to as tissue) by utilizing radio frequency energy. A lumen 108 extends through the distal tip section 104 which defines a lumen entrance 106 extending from the lumen 108. The distal tip section 104 (preferably) has an exterior shape that is partially coated with a dielectric surface 112. This partial coating (of the dielectric surface 112) is configured to reduce tissue coring (shown in the embodiment of FIG. 1). A portion of the distal tip section 104 may have a portion (of the electrically active periphery) of an electrically conductive material (the conductive surface 110) positioned on the distal tip section 104. A portion of the circumference of the distal tip section 104 is dielectrically coated (with a dielectric surface 112) to avoid tissue separation when radio frequency energy is applied to the distal tip section 104 (as shown in FIG. 1).

[0046] 5, the needle assembly 102 can include (define) a lumen entrance 106 that leads to a lumen 108. The lumen entrance 106 is located at the distal tip section 104. A dielectric coating (dielectric surface 112) is applied to at least one or more sections of the distal tip section 104 (surrounding the lumen entrance 106 at the distal tip section 104) to prevent tissue coring (as shown in the embodiment of FIG. 1). The dielectric coating (dielectric surface 112) can cover at least a portion of the perimeter surrounding the lumen entrance 106 defined in the distal tip section 104.

[0047] With reference to the embodiment shown in FIG. 5, the exposed conductive surface 110 and the exposed dielectric surface 112 are configured to cover different portions (sections) of the distal tip section 104 .

[0048] With reference to the embodiment shown in FIG. 5, exposed dielectric surface 112 can be positioned proximate (adjacent) to exposed conductive surface 110 .

[0049] With reference to the embodiment shown in FIG. 5, the exposed conductive surface 110 and the exposed dielectric surface 112 are each configured to at least partially contact the biological wall 904 (preferably when or while the needle assembly 102 is biased to move toward the biological wall 904, as shown in the embodiment of FIG. 4).

[0050] With reference to the embodiment shown in FIG. 5, the dielectric surface 112 comprises a chemical vapor deposited poly(p-xylylene) polymer configured to provide a moisture and dielectric barrier, such as (preferably) Parylene™. The dielectric surface 112 (dielectric coating) partially covers the distal tip section 104. The thickness of the dielectric coating may be such that no dielectric breakdown occurs under the electrical parameters utilized by the radio frequency generator with which the distal tip section 104 is configured to interact. For example, the thickness of the dielectric coating may be at least about 30 micrometers, and the final appropriate coating thickness may depend on the electrical parameters used for the needle assembly 102. It will be appreciated that any material of sufficient dielectric strength to prevent the transmission of electricity (such as radio frequency energy) to a portion of the circumference of the distal tip section 104 may be acceptable. It will be appreciated that any material of sufficient dielectric strength to prevent the transmission of electricity (radio frequency energy) to the coated portion of the distal tip section 104 may be acceptable. Additionally, the dielectric coating may be applied to the interior of the lumen entrance 106 and / or lumen 108, for example.

[0051] 5, the dielectric surface 112 has a parylene thickness of (preferably) about 30 micrometers. The dielectric surface 112 may include other suitable coatings or materials, such as silicon dioxide, aluminum oxide, any alternative formulation of parylene, silicone-based coating formulations, fluoropolymer coatings, and any equivalents thereof.

[0052] Referring to the embodiment shown in FIG. 5, according to one option, a dielectric surface 112 is applied to the outer portion of the distal tip section 104, which may be sufficient to prevent tissue coring (as shown in FIG. 1).

[0053] Referring to the embodiment shown in Figure 5, according to another option, a dielectric surface 112 may be applied to the inner surface of the lumen entrance 106 and / or lumen 108. While the needle assembly 102 penetrates tissue (i.e., biological wall 904 as shown in Figure 4), the interior of the needle assembly 102 is in close proximity to the biological wall 904 (tissue). While the inner surface of the lumen entrance 106 and / or lumen 108 may not necessarily directly touch the biological wall 904, the proximity of the inner surfaces may be close enough that electrical arcing may occur and inadvertently cut the tissue (which may be undesirable), thus causing tissue coring (as shown in Figure 1). To alleviate such a condition, a length, such as about 5 millimeters (mm), of the inner surface of the lumen entrance 106 and / or lumen 108 may be coated with a dielectric surface 112 that may prevent undesired (electrical) arcing that may occur from within the distal tip section 104 when the distal tip section 104 of the needle assembly 102 penetrates the biological wall 904 (as shown in FIG. 4 ).

[0054] Referring to the embodiment as shown in Figure 6 (end view), a circumferential profile (of the distal tip section 104) is shown. The distal tip section 104 includes (preferably) a first arcuate portion 200 and a second arcuate portion 202 positioned proximate to the first arcuate portion 200. The distal tip section 104 includes (preferably) a circumferential peripheral leading edge 105. The circumferential peripheral leading edge 105 includes (preferably) the first arcuate portion 200 and the second arcuate portion 202.

[0055] 6, a portion of the distal tip section 104 (the dielectric surface 112) is coated with a dielectric material configured to provide electrical insulation. For example, when radio frequency energy is applied to the distal tip section 104, the uncoated portion of the distal tip section 104 (the active portion not coated with the dielectric material) is activated (energized) and can cut tissue (biological wall 904), while the portion coated with the dielectric material cannot (does not) cut tissue. As a result, there is no tissue separation that occurs (as with the embodiment of FIG. 1).

[0056] 6 , the distal tip section 104 includes a first arcuate portion 200 and a second arcuate portion 202 positioned proximate to the first arcuate portion 200. The exposed conductive surface 110 is also configured to cover the first arcuate portion 200. The exposed dielectric surface 112 is also configured to cover (covers) the second arcuate portion 202 of the distal tip section 104.

[0057] With reference to the embodiment shown in FIG. 6, the exposed conductive surface 110 is also configured to electrically cut through the biological wall 904 (preferably when the exposed conductive surface 110 of the distal tip section 104 is moved into at least partial contact with the biological wall 904 during use, and when (or while) the exposed conductive surface 110 is activated to cut through the biological wall 904).

[0058] 6, the exposed dielectric surface 112 is also configured to electrically isolate a portion of the distal tip section 104 surrounding the lumen entrance 106 from the biological wall 904. This preferably occurs when (or while) the exposed conductive surface 110 contacts the biological wall 904 during use, and when the exposed conductive surface 110 is activated to form a through hole 905 extending through the biological wall 904 (and while the needle assembly 102 is biased to move towards the biological wall 904, as shown in the embodiment of FIG. 4).

[0059] With reference to the embodiment shown in FIG. 6 , the exposed dielectric surface 112 is configured to electrically isolate a portion of the distal tip section 104 surrounding the luminal entrance 106 from the biological wall 904 (while the exposed conductive surface 110 is activated, the exposed dielectric surface 112 avoids the formation of the free-floating tissue core 906 shown in the embodiment of FIG. 1 ).

[0060] 6, the distal tip section 104 presents (has) a circumferential peripheral leading edge 105 that surrounds the luminal entrance 106. The circumferential peripheral leading edge 105 is configured to prevent removal of the free-floating tissue core 906 from the biological wall 904 (when or during the through-hole 905 is formed by the distal tip section 104).

[0061] 6, the exposed conductive surface 110 is configured to cover a first arcuate portion 200 of the circumferential peripheral leading edge 105. The exposed dielectric surface 112 is configured to cover a second arcuate portion 202 of the circumferential peripheral leading edge 105. The second arcuate portion 202 is positioned proximate to the first arcuate portion 200. The exposed dielectric surface 112 is positionable proximate to the exposed conductive surface 110. The exposed conductive surface 110 and the exposed dielectric surface 112 are each configured to at least partially contact the biological wall 904 (when or while the needle assembly 102 is moved towards the biological wall 904 during use).

[0062] Figures 7, 8, 9, and 10 show a cross-sectional view (Figure 7) and a side view (Figures 8, 9, and 10) of an embodiment of the needle assembly 102 of Figure 2. The view shown in Figure 7 is taken along section line AA of Figure 6.

[0063] 7 (cross-sectional view), a dielectric surface 112 (also called a dielectric coating or electrical insulation) is applied to the inner surface facing the lumen 108 and / or lumen entrance 106. This configuration mitigates unwanted (electrical) arcing that can occur when tissue (biological wall 904, as shown in FIG. 4) passes close to the distal tip section 104 (which can result in tissue coring as shown in FIG. 1).

[0064] 8, 9, and 10, various embodiments of the side profile of the distal tip section 104 are shown. In some embodiments, the distal tip section 104 has a tapered profile configured to facilitate passing through a biological wall 904 (as shown in FIG. 4). Initially, a cross-sectional section smaller than the overall diameter of the distal tip section 104 penetrates the biological wall 904 (tissue wall), and then as the tapered section travels through the biological wall 904 (cross-section), the cross-section is progressively expanded wider until the diameter of the distal tip section 104 becomes relatively larger.

[0065] With reference to the embodiment shown in FIG. 8, the distal tip section 104 presents a sloped leading surface.

[0066] With reference to the embodiment shown in FIG. 9, the distal tip section 104 provides a blunt portion with a tapered profile. The blunt distal tip mitigates skiving of plastic material that may occur as the needle assembly 102 advances through an accessory device (known to those skilled in the art and not shown). The tapered profile is configured to enhance crossing through the biological wall 904 (as shown in FIG. 4), such as a septal crossing effect, since the size of the hole (through hole 905, as shown in FIG. 4) initially created via puncture (by utilization of the needle assembly 102) is smaller compared to the overall diameter of the distal tip section 104. The tapered profile is configured to allow the puncture hole (through hole 905) to gradually expand to a relatively larger diameter, creating a smooth sensation rather than an abrupt jump when crossing the biological wall 904 (such as the atrial septum of the heart). It will be appreciated that any profile (external shape) of the distal tip section 104 may be utilized. The distal tip section 104 preferably provides or defines a lumen entrance 106 that leads to a lumen 108 positioned within the needle assembly 102 .

[0067] With reference to the embodiment shown in FIG. 10, the distal tip section 104 presents a forwardly extending extension of the sloped leading surface.

[0068] 11 and 12 show perspective views of an embodiment of the needle assembly 102 of FIG.

[0069] 11 and 12, an extension section 116 of the distal tip section 104 extends (forwardly) from the distal tip section 104. The extension section 116 is made of (includes) a conductive surface 110, and the remainder of the contour of the distal tip section 104 (or the circumferential leading edge 105) is coated with a dielectric material (i.e., the dielectric surface 112 includes the remainder of the contour of the distal tip section 104 or the circumferential leading edge 105). For example, this may be advantageous to prevent application of radio frequency energy to tissue in these regions (at the biological wall 904).

[0070] FIG. 13 illustrates a perspective view of an embodiment of the needle assembly 102 of FIG.

[0071] With reference to the embodiment shown in Figure 13, the distal tip section 104 is shown crossing a biological wall 904. Radiofrequency energy is applied to tissue (via conductive surface 110) at the uncoated portion of the distal tip section 104, while the remainder of the section of the needle assembly 102 proximate to the tissue is covered with a dielectric coating (forming dielectric surface 112 thereon). Tissue vaporizes only at the conductive surface 110 (i.e., the uncoated portion of the distal tip section 104). According to the embodiment of Figure 13, the needle assembly 102 does not provide or include a lumen entrance 106 and / or a lumen 108 (e.g., items shown in the embodiment of Figure 2).

[0072] With reference to the embodiment as shown in FIG. 13, the main aspects of the device are shown. The device includes, but is not limited to, a needle assembly 102. The needle assembly 102 is configured to be movable into a cavity 900 of a patient 902 having a biological wall 904 (an internal biological wall). A distal tip section 104 extends (distally) from the needle assembly 102. The distal tip section 104 is configured to form a through hole 905 extending through the biological wall 904 of the patient 902 when (while) the needle assembly 102 is biased to move towards the biological wall 904 (as shown in the embodiment of FIG. 4). The distal tip section 104 is also configured to prevent removal of a free-floating tissue core 906 (as shown in the embodiment of FIG. 1) from the biological wall 904 when (or while) the through hole 905 is formed by the distal tip section 104.

[0073] With reference to the embodiment shown in FIG. 13, the exposed conductive surface 110 and the exposed dielectric surface 112 are configured to cover different portions of the distal tip section 104 .

[0074] With reference to the embodiment shown in FIG. 13, exposed dielectric surface 112 can be positioned proximate (adjacent) to exposed conductive surface 110 .

[0075] With reference to the embodiment shown in FIG. 13, when (or during) the needle assembly 102 is biased to move toward the biological wall 904 (as shown in the embodiment of FIG. 4), the exposed conductive surface 110 and the exposed dielectric surface 112 are each configured to at least partially contact the biological wall 904.

[0076] With reference to the embodiment as shown in Figure 13, the main aspects of the device are shown. The method is for forming a through hole 905 through a biological wall 904 of a patient 902 having a cavity 900. The method includes, but is not limited to, including a first operation including moving a needle assembly 102 into the cavity 900 of the patient 902 having the biological wall 904. The needle assembly 102 includes a distal tip section 104 extending (distally) from the needle assembly 102. The method includes, but is not limited to, including a first operation including forming a through hole 905 through the biological wall 904 of the patient 902 using the distal tip section 104 while the needle assembly 102 is urged to move toward the biological wall 904 (as shown in the embodiment of Figure 4). The method includes, and is not limited to (including), a first operation involving using the distal tip section 104 to prevent removal of a free-floating tissue core 906 (shown in the embodiment of FIG. 1 ) from the biological wall 904 when (or during) the through hole 905 is formed by the distal tip section 104.

[0077] The following is proposed as a further description of embodiments in which any one or more of the optional technical features (described in the detailed description, abstract, and claims) can be combined with any one or more of the optional technical features (described in the detailed description, abstract, and claims). Each claim in the claim paragraph is understood to be an open-ended claim unless otherwise specified. Unless otherwise specified, the relevant terms used in these specifications should be interpreted to include certain tolerances that a person skilled in the art would recognize to provide equivalent functionality. As an example, the term vertical is not necessarily limited to 90.0 degrees, but may include variations thereof that a person skilled in the art would recognize to provide equivalent functionality for the described purpose for the relevant member or element. Terms such as "about" and "substantially" in the context of a configuration generally relate to an arrangement, configuration, or configuration that is exactly or sufficiently close to the arrangement, configuration, or configuration of the relevant elements to maintain the operability of the elements in the present disclosure without substantially altering the disclosure. Similarly, unless made clear from the context, numerical values ​​should be interpreted to include certain tolerances that a person skilled in the art would recognize as not substantially altering the operability of the disclosure and therefore of negligible importance. It will be understood that the description and / or drawings identify and describe embodiments (either explicitly or inherently) of the device. The device may include any suitable combination and / or permutation of the technical features identified in the detailed description, as may be required and / or desired to serve a particular technical purpose and / or technical function. It will be understood that, where possible and preferred, any one or more technical features of the device may be combined (in any combination and / or permutation) with any other one or more technical features of the device. It will be understood that a person skilled in the art will know that the technical features of each embodiment may be deployed in other embodiments, even if not explicitly stated as above. A person skilled in the art will understand that other options for the configuration of the components of the device are possible, adjusting to manufacturing requirements and remaining within the scope of at least one or more of the claims.The specification provides embodiments, including the best mode, and also enables one skilled in the art to make and use the embodiments. The patentable scope may be defined by the claims. The written description and / or drawings may aid in understanding the scope of the claims. It is believed that all material aspects of the disclosed subject matter are provided herein. In this specification, the word "includes" is understood to be equivalent to the word "comprising," in that both words are used to indicate a non-limiting list of antecedents, components, parts, etc. The term "comprising," which is synonymous with the terms "including," "containing," or "characterized by," is inclusive or open-ended and does not exclude additional, unrecited elements or method steps. Comprising (comprised of) is an "open-ended" phrase, allowing for scope of the technology to employ additional, unrecited elements. When used in the claims, the word "comprising" is a transitive verb (transitional term) that separates the preamble of the claim from the technical features of the present disclosure. The foregoing has outlined non-limiting embodiments. The description is directed to specific non-limiting embodiments. It is understood that the non-limiting embodiments are merely illustrative as examples.

Claims

1. An apparatus comprising: a needle assembly configured to be movable into a cavity of a patient having a biological wall, the needle assembly comprising: a distal tip section extending from the needle assembly and coated with a dielectric material; an extension section having a conductive surface extending distally from the distal tip section; Including, the distal tip section is configured to form a throughbore extending through the biological wall of the patient when the needle assembly is biased to move toward the biological wall; The device, wherein the distal tip section and the extension section are configured to at least partially prevent removal of a free-floating tissue core from the biological wall when the through hole is formed by the distal tip section.

2. The device of claim 1 , wherein the distal tip section includes a lumen entrance that leads to a lumen extending internally along the length of the needle assembly.

3. The device of claim 2 , wherein the distal tip section presents a circumferential leading edge surrounding the lumen entrance, the circumferential leading edge being coated with the dielectric material.

4. The device of claim 1 , wherein the dielectric material comprises parylene, silicon dioxide, aluminum oxide, a silicone-based coating formulation, or a fluoropolymer.

5. An apparatus comprising: a needle assembly constructed from a conductive material and configured to receive a radio frequency energy source and be movable into a cavity of a patient having a biological wall; a distal tip section extending from the needle assembly and having a tapered profile; the distal tip section is constructed from the conductive material and has an outer surface, an inner surface defining a lumen, and a leading edge defining an entrance to the lumen, the distal tip section having exposed conductive surfaces and exposed dielectric surfaces configured to cover different portions of the distal tip section; the distal tip section is configured to create a through hole extending through the biological wall of the patient with radio frequency energy when the needle assembly is urged to move toward the biological wall; The distal tip section is also configured to at least partially prevent removal of a free-floating tissue core from the biological wall when the through hole is formed by the distal tip section.

6. 6. The device of claim 5, wherein the tapered profile is configured such that a cross-sectional section smaller than the overall diameter of the distal tip section passes through the through hole and then the through hole is gradually expanded wider as the tapered profile moves through the biological wall.

7. The device of claim 5 , wherein the distal tip section includes an extension portion extending forward of a sloped leading surface.

8. 6. The apparatus of claim 5, wherein the exposed dielectric surface comprises parylene, silicon dioxide, aluminum oxide, a silicone-based coating formulation, or a fluoropolymer.

9. The apparatus of claim 5 , wherein the exposed dielectric surface is positionable proximate to the exposed conductive surface.

10. 6. The device of claim 5, wherein the exposed conductive surface and the exposed dielectric surface are each configured to at least partially contact the biological wall when the needle assembly is urged to move toward the biological wall.

11. 6. The device of claim 5, wherein the distal tip section is also configured to form a tissue flap that remains attached to and extends from the biological wall when the through hole is formed by the distal tip section, the tissue flap being positioned adjacent to the through hole.

12. 6. The device of claim 5, wherein the exposed conductive surface is also configured to electrically cut through the biological wall when the exposed conductive surface of the distal tip section is moved during use into at least partial contact with the biological wall and activated to cut through the biological wall.

13. 6. The device of claim 5, wherein the exposed dielectric surface is also configured to electrically isolate a portion of the distal tip section surrounding a lumen entrance from the biological wall when the exposed conductive surface contacts the biological wall in use and when the exposed conductive surface is activated to form a through hole extending through the biological wall while the needle assembly is biased to move toward the biological wall.

14. The device of claim 5 , wherein the leading edge is configured to at least partially prevent removal of a free-floating tissue core from the biological wall when the through hole is formed by the distal tip section.

15. 15. The apparatus of claim 14, wherein the exposed conductive surface is configured to cover a first portion of the leading edge and the exposed dielectric surface is configured to cover a second portion of the leading edge.

Images